...
首页> 外文期刊>International Journal of Nephrology and Renovascular Disease >Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
【24h】

Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure

机译:血液透析过程中再次注入腹水以治疗大量难治性腹水和急性肾衰竭

获取原文

摘要

Abstract: Refractory ascites can occur in patients with various conditions. Although several procedures based on the reinfusion of ascitic fluid have been reported after the failure of bed rest, salt and water restriction, diuretics, intravenous administration of albumin, and repeated paracentesis, these procedures are performed for ascitic fluid removal without dialytic effect. In this study, a flow control reinfusion of ascites during hemodialysis (HD) was performed to demonstrate the efficacy of this method in a lupus patient with massive refractory ascites and respiratory and acute renal failure (ARF). The alleviation of ascites and ARF attests to the success of the flow control reinfusion of ascites during HD. This procedure can control the rate of ascites and body fluid removal simultaneously during HD using the roller pump. In conclusion, with a normal coagulation profile, the procedure of flow control reinfusion of ascites during HD is an effective alternative treatment for the alleviation of refractory ascites with renal failure.
机译:摘要:难治性腹水可在各种情况下发生。尽管在卧床休息失败,盐和水限制,利尿剂,白蛋白的静脉内给药和反复穿刺术失败后,已经报道了几种基于腹水再输注的程序,但这些程序用于去除腹水而无透析作用。在这项研究中,进行了血液透析(HD)过程中腹水的流量控制回输,以证明该方法在患有大量难治性腹水以及呼吸和急性肾衰竭(ARF)的狼疮患者中的有效性。腹水和ARF的减轻证明了HD期间腹水流量控制回输的成功。该过程可在使用滚子泵进行HD期间同时控制腹水率和体液清除率。总之,在正常的凝血状态下,HD期间腹水的流量控制回输是减轻肾衰竭难治性腹水的有效替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号